Concas A, Follesa P, Barbaccia M L, Purdy R H, Biggio G
Department of Experimental Biology, University of Cagliari, Italy.
Eur J Pharmacol. 1999 Jun 30;375(1-3):225-35. doi: 10.1016/s0014-2999(99)00232-0.
The possible functional relation between changes in brain and plasma concentrations of neurosteroids and the plasticity of gamma-aminobutyric acid type A (GABA(A)) receptors in the brain during pregnancy and after delivery was investigated in rats. The concentrations in the cerebral cortex and plasma of pregnenolone as well as of progesterone and its neuroactive derivatives allopregnanolone (3alpha-hydroxy-5alpha-pregnan-20-one) and allotetrahydrodeoxycorticosterone (5alpha-hydroxy-3alpha,21-diol-20-one) increased during pregnancy, peaking around day 19, before returning to control (estrus) values immediately before delivery (day 21). In the postpartum period, steroid concentrations in plasma and brain did not differ from control values. The densities of [3H]GABA, [3H]flunitrazepam, and t-[35S]butylbicyclophosphorotionate (TBPS) binding sites in the cerebral cortex also increased during pregnancy, again peaking on day 19 and returning to control values on day 21; receptor density was decreased further 2 days after delivery and again returned to control values within 7 days. These changes were accompanied by a decrease in the apparent affinity of the binding sites for the corresponding ligand on day 19 of pregnancy. The amount of the gamma2L subunit mRNA decreased progressively during pregnancy, in the cerebral cortex and hippocampus, returned to control value around the time of delivery and did not change in the postpartum period. On the contrary, the amount of alpha4 subunit mRNA was not modified during pregnancy both in the cerebral cortex and hippocampus whereas significantly increased 7 days after delivery only in the hippocampus. No significant changes were apparent for alpha1, alpha2, alpha3, beta1, beta2, beta3 and gamma2S subunit mRNAs. Administration of finasteride, a specific 5alpha-reductase inhibitor, to pregnant rats from days 12 to 18 markedly reduced the increases in the plasma and brain concentrations of allopregnanolone and allotetrahydrodeoxycorticosterone as well as prevented both the increase in the densities of [3H]flunitrazepam and [35S]TBPS binding sites and the decrease of gamma2L mRNA normally observed during pregnancy. The results demonstrate that the changes in the plasticity of GABA(A) receptors that occur in rat brain during pregnancy and after delivery are related to the physiological changes in plasma and brain concentrations of neurosteroids.
在大鼠中研究了孕期和产后大脑与血浆中神经甾体浓度变化之间可能的功能关系,以及大脑中γ-氨基丁酸A型(GABA(A))受体的可塑性。孕期皮质醇、孕酮及其神经活性衍生物别孕烯醇酮(3α-羟基-5α-孕烷-20-酮)和别四氢脱氧皮质酮(5α-羟基-3α,21-二醇-20-酮)在大脑皮质和血浆中的浓度均升高,在第19天左右达到峰值,然后在分娩前(第21天)立即恢复到对照(发情期)值。产后,血浆和大脑中的甾体浓度与对照值无差异。孕期大脑皮质中[3H]GABA、[3H]氟硝西泮和t-[35S]丁基双环磷硫化物(TBPS)结合位点的密度也增加,同样在第19天达到峰值,并在第21天恢复到对照值;分娩后2天受体密度进一步降低,并在7天内再次恢复到对照值。这些变化伴随着孕期第19天结合位点对相应配体的表观亲和力下降。大脑皮质和海马中γ2L亚基mRNA的量在孕期逐渐减少,在分娩时恢复到对照值,产后无变化。相反,大脑皮质和海马中α4亚基mRNA在孕期未发生改变,而仅在产后7天海马中显著增加。α1、α2、α3、β1、β2、β3和γ2S亚基mRNA无明显变化。从第12天至18天给怀孕大鼠施用特异性5α-还原酶抑制剂非那雄胺,可显著降低别孕烯醇酮和别四氢脱氧皮质酮在血浆和大脑中的浓度升高,并防止孕期通常观察到的[3H]氟硝西泮和[35S]TBPS结合位点密度增加以及γ2L mRNA减少。结果表明,大鼠大脑孕期和产后期间GABA(A)受体可塑性的变化与血浆和大脑中神经甾体浓度的生理变化有关。